Showing results (1-10 of 5) with videos related to
Sort By:
Pageof 1
Journal of Gastroenterology|April 6, 2004
Early decrease in serum IV-7S levels during IFN treatment predicts anti-fibrogenic effect in nonresponders with chronic hepatitis CShintaro Abe, Ryouichi Narita, Masaaki Hiura, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|March 20, 2003
High-dose interferon-alpha therapy lowers the levels of serum fibrogenesis markers over 5 years in chronic hepatitis CShintaro Abe, Akinari Tabaru, Masami Ono, et al.Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|August 6, 2011
A case of splenic artery aneurysm simulating a pancreas tumorHideyasu Nagamatsu, Ken Takahashi, Tetsuya Ueo, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 19, 2019
Efficacy and safety of glecaprevir/pibrentasvir as retreatment therapy for patients with genotype 2 chronic hepatitis C who failed prior sofosbuvir plus ribavirin regimenAtsunori Kusakabe, Masayuki Kurosaki, Jun Itakura, et al.Journal of Gastroenterology|April 8, 2018
Real-world efficacy and safety of ledipasvir and sofosbuvir in patients with hepatitis C virus genotype 1 infection: a nationwide multicenter study by the Japanese Red Cross Liver Study GroupKeiji Tsuji, Masayuki Kurosaki, Jun Itakura, et al.Pageof 1